Daily ingestion of purified extract of pomegranate polyphenols in HD patients produced a significant increase in PON1 activity compared to the placebo group, without having any effect on other markers of CVD risk, inflammation or oxidative stress [82]. This evidence concerns the gene PON1 and Huntington disease.